Deborah S Keller1, Nisreen Madhoun1, Juan Ramon Flores-Gonzalez1, Sergio Ibarra1, Reena Tahilramani2, Eric M Haas3. 1. Colorectal Surgical Associates LLP LTD, Houston, TX, USA. 2. Colorectal Surgical Associates LLP LTD, Minimally Invasive Colon and Rectal Surgery, The University of Texas Medical School at Houston, Houston, TX, USA. 3. Division of Colon and Rectal Surgery, Colorectal Surgical Associates LLP LTD, Houston Methodist Hospital, Minimally Invasive Colon and Rectal Surgery, The University of Texas Medical School at Houston, 6560 Fannin, Suite 1404, Houston, TX, 77030, USA. ehaasmd@houstoncolon.com.
Abstract
BACKGROUND: Many benefits of minimally invasive surgery are lost in the obese, but robotic-assisted laparoscopic surgery (RALS) may offer advantages in this population. Our goal was to compare outcomes for RALS in obese and non-obese patients. METHODS: A prospective database was reviewed for colorectal resections using RALS. Patients were stratified into obese (BMI > 30 kg/m(2)) and non-obese cohorts (BMI < 30 kg/m(2)), then case-matched for comparability. The main outcome measures were operative time, conversion rate, length of stay and complication, readmission, and reoperation rates between groups. RESULTS: Forty-five patients were evaluated in each cohort. The BMI was significantly different (p < 0.01). All other demographics were well matched. There were no significant differences in operative time (p = 0.86), blood loss (p = 0.38), intraoperative complications (p = 0.54), or conversion rates (p = 0.91) across cohorts. Length of stay was comparable between groups (p = 0.45). Postoperatively, the complication (p = 0.87), readmission (p = 1.00), and reoperation rates (p = 0.95) were similar. There were no mortalities. For malignant cases (37.8 %), the lymph node yield (p = 0.48) and positive margins (p = 1.00) were similar and acceptable in both cohorts. CONCLUSIONS: In our matched RALS series, perioperative and postoperative outcomes were similar between obese and non-obese patients undergoing colorectal surgery. RALS is a feasible option in the surgical setting of the obese patient. Further controlled studies are warranted to explore the full benefits.
BACKGROUND: Many benefits of minimally invasive surgery are lost in the obese, but robotic-assisted laparoscopic surgery (RALS) may offer advantages in this population. Our goal was to compare outcomes for RALS in obese and non-obesepatients. METHODS: A prospective database was reviewed for colorectal resections using RALS. Patients were stratified into obese (BMI > 30 kg/m(2)) and non-obese cohorts (BMI < 30 kg/m(2)), then case-matched for comparability. The main outcome measures were operative time, conversion rate, length of stay and complication, readmission, and reoperation rates between groups. RESULTS: Forty-five patients were evaluated in each cohort. The BMI was significantly different (p < 0.01). All other demographics were well matched. There were no significant differences in operative time (p = 0.86), blood loss (p = 0.38), intraoperative complications (p = 0.54), or conversion rates (p = 0.91) across cohorts. Length of stay was comparable between groups (p = 0.45). Postoperatively, the complication (p = 0.87), readmission (p = 1.00), and reoperation rates (p = 0.95) were similar. There were no mortalities. For malignant cases (37.8 %), the lymph node yield (p = 0.48) and positive margins (p = 1.00) were similar and acceptable in both cohorts. CONCLUSIONS: In our matched RALS series, perioperative and postoperative outcomes were similar between obese and non-obesepatients undergoing colorectal surgery. RALS is a feasible option in the surgical setting of the obesepatient. Further controlled studies are warranted to explore the full benefits.
Authors: Ruben Veldkamp; Esther Kuhry; Wim C J Hop; J Jeekel; G Kazemier; H Jaap Bonjer; Eva Haglind; Lars Påhlman; Miguel A Cuesta; Simon Msika; Mario Morino; Antonio M Lacy Journal: Lancet Oncol Date: 2005-07 Impact factor: 41.316
Authors: Mukta K Krane; Marco E Allaix; Marco Zoccali; Konstantin Umanskiy; Michele A Rubin; Anthony Villa; Roger D Hurst; Alessandro Fichera Journal: J Am Coll Surg Date: 2013-03-21 Impact factor: 6.113
Authors: Heidi Nelson; Daniel J Sargent; H Sam Wieand; James Fleshman; Mehran Anvari; Steven J Stryker; Robert W Beart; Michael Hellinger; Richard Flanagan; Walter Peters; David Ota Journal: N Engl J Med Date: 2004-05-13 Impact factor: 91.245
Authors: E Duchalais; N Machairas; S R Kelley; R G Landmann; A Merchea; D T Colibaseanu; K L Mathis; E J Dozois; D W Larson Journal: Surg Endosc Date: 2018-07-09 Impact factor: 4.584